Inventor · disambiguated record
Silvia Fratarcangeli
Also filed as: FRATARCANGELI SILVIA
10 granted patents·6 pending applications·48 citations·filing 2015–2022
88Inventor score
Top patents by PatentIndex Score
16 records- 0195US10493152B2Adalimumab formulationsFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2015·Granted Dec 3, 2019·10 cites·14 claims
- 0295US10426832B2Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2015·Granted Oct 1, 2019·10 cites·9 claims
- 0394US11752209B2Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2022·Granted Sep 12, 2023·1 cites·11 claims
- 0494US10426833B2Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2015·Granted Oct 1, 2019·10 cites·19 claims
- 0593US10772961B2Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2019·Granted Sep 15, 2020·6 cites·26 claims
- 0692US10729769B2Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2019·Granted Aug 4, 2020·8 cites·17 claims
- 0788US11707524B2Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2021·Granted Jul 25, 2023·1 cites·11 claims
- 0887US11712471B2Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2020·Granted Aug 1, 2023·1 cites·13 claims
- 0986US11752208B2Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2020·Granted Sep 12, 2023·1 cites·6 claims
- 1084US12109267B2Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2022·Granted Oct 8, 2024·0 cites·11 claims
- 1176US2021308262A1Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2021·Application pending·0 cites
- 1276US2021322551A1Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2021·Application pending·0 cites
- 1372US2021121566A1Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2020·Application pending·0 cites
- 1464US2020155677A1Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2019·Application pending·0 cites
- 1542US2020016267A1Aqueous anti-pd-l1 antibody formulationMERCK PATENT GMBH·Filed 2018·Application pending·0 cites
- 1636US2018296674A1Liquid pharmaceutical compositionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →